| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: Q4QB01
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 82 | 86 | PF00656 | 0.663 |
| CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.382 |
| CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.651 |
| CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.629 |
| CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.382 |
| CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.491 |
| CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.723 |
| CLV_PCSK_PC1ET2_1 | 129 | 131 | PF00082 | 0.491 |
| CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.451 |
| CLV_PCSK_SKI1_1 | 18 | 22 | PF00082 | 0.674 |
| CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.662 |
| DOC_CYCLIN_RxL_1 | 23 | 34 | PF00134 | 0.485 |
| DOC_USP7_UBL2_3 | 29 | 33 | PF12436 | 0.409 |
| DOC_USP7_UBL2_3 | 77 | 81 | PF12436 | 0.586 |
| LIG_Actin_WH2_2 | 29 | 46 | PF00022 | 0.464 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.483 |
| LIG_deltaCOP1_diTrp_1 | 85 | 91 | PF00928 | 0.614 |
| LIG_FHA_1 | 19 | 25 | PF00498 | 0.421 |
| LIG_FHA_1 | 54 | 60 | PF00498 | 0.396 |
| LIG_LIR_Apic_2 | 41 | 45 | PF02991 | 0.410 |
| LIG_LIR_Gen_1 | 109 | 118 | PF02991 | 0.593 |
| LIG_LIR_Nem_3 | 108 | 114 | PF02991 | 0.606 |
| LIG_LIR_Nem_3 | 88 | 94 | PF02991 | 0.617 |
| LIG_Pex14_1 | 87 | 91 | PF04695 | 0.619 |
| LIG_SH2_STAP1 | 10 | 14 | PF00017 | 0.489 |
| LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.596 |
| LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.434 |
| LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.488 |
| LIG_SH3_4 | 29 | 36 | PF00018 | 0.407 |
| LIG_TRAF2_2 | 105 | 110 | PF00917 | 0.704 |
| LIG_TYR_ITSM | 107 | 114 | PF00017 | 0.609 |
| LIG_WRC_WIRS_1 | 54 | 59 | PF05994 | 0.437 |
| MOD_CK2_1 | 110 | 116 | PF00069 | 0.612 |
| MOD_GSK3_1 | 106 | 113 | PF00069 | 0.616 |
| MOD_GSK3_1 | 53 | 60 | PF00069 | 0.488 |
| MOD_NEK2_1 | 31 | 36 | PF00069 | 0.396 |
| MOD_NEK2_1 | 57 | 62 | PF00069 | 0.475 |
| MOD_PKA_2 | 43 | 49 | PF00069 | 0.411 |
| MOD_Plk_2-3 | 110 | 116 | PF00069 | 0.596 |
| TRG_DiLeu_BaLyEn_6 | 27 | 32 | PF01217 | 0.481 |
| TRG_ENDOCYTIC_2 | 111 | 114 | PF00928 | 0.596 |
| TRG_ER_diArg_1 | 22 | 24 | PF00400 | 0.512 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PDE3 | Leptomonas seymouri | 81% | 99% |
| A0A0S4ILZ1 | Bodo saltans | 55% | 100% |
| A0A1X0NXD3 | Trypanosomatidae | 59% | 93% |
| A0A3S7WY14 | Leishmania donovani | 98% | 100% |
| A0A422NJI6 | Trypanosoma rangeli | 59% | 98% |
| A4HD22 | Leishmania braziliensis | 92% | 97% |
| A4I0K9 | Leishmania infantum | 98% | 100% |
| C9ZVI3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 99% |
| E9AWH0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
| V5BFT8 | Trypanosoma cruzi | 64% | 95% |